← Leaderboards
Anup Kumer Kundu
Xavier University Of Louisiana
$448,500
Attributed
$448,500
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $112.5K · FY2021–24$200K$150K$100K$50K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$448,500 · 1
By mechanism
SC3$448,500 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Chemoresistance”
- Ozgur Sahin · Medical University Of South Carolina$4,595,535
- Mazhar Adli · University Of Virginia$4,305,546
- Carrie Danielle House · San Diego State University$3,947,730
- Muller Fabbri · Children'S Hospital Of Los Angeles$3,343,679
- Costas Andreas Lyssiotis · University Of Michigan At Ann Arbor$2,648,456
- Lingtao Jin · University Of Texas Hlth Science Center$2,525,337
Research focus
ChemoresistanceChemotherapy-Oncologic ProcedureAbcc1 GeneAbcb1 GeneAbcg2 GeneAnti-Cancer TherapeuticAntineoplastic AgentsAntitumor EffectAptamerAptamer TechnologyAtp-Binding Cassette TransportersAnti-CancerBindingBreast Cancer CellBreast Cancer TherapyBreast Cancer TreatmentBypassCancer CellCancer Drug ResistanceCancer TherapyCardiomyopathiesCardiotoxicityCellsClinical Application
Grant awards (4)
Formulation of a targeted nanoparticle system for the treatment of chemoresistant breast cancer$112,500
SC3 · FY2024 · GM · contact PI
Formulation of a targeted nanoparticle system for the treatment of chemoresistant breast cancer$112,500
SC3 · FY2023 · GM · contact PI
Formulation of a targeted nanoparticle system for the treatment of chemoresistant breast cancer$112,500
SC3 · FY2022 · GM · contact PI
Formulation of a targeted nanoparticle system for the treatment of chemoresistant breast cancer$111,000
SC3 · FY2021 · GM · contact PI